Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    "Pemphigus"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Condition: Pemphigus
Intervention: Drug: Sirolimus (formerly known as Rapamycin)
2 Unknown  Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Condition: Pemphigus
Intervention: Drug: Rituximab
3 Terminated Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Ofatumumab;   Drug: Acetaminophen/paracetamol;   Drug: Antihistamine (cetirizine or equivalent);   Drug: Prednisone/Prednisolone
4 Active, not recruiting Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Interventions: Drug: VAY736;   Drug: Placebo to VAY736
5 Completed Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Condition: Pemphigus
Intervention: Drug: Rituximab
6 Unknown  Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
7 Completed Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
8 Completed European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Condition: Pemphigus
Intervention: Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)
9 Terminated
Has Results
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Condition: Pemphigus Vulgaris
Interventions: Drug: intravenous immunoglobulin;   Drug: cyclophosphamide
10 Completed Effect of Anti CD20 in Pemphigus Desease
Condition: Pemphigus
Intervention: Drug: Mabthera
11 Terminated Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Biological: Ofatumumab;   Biological: Placebo
12 Completed
Has Results
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo
13 Completed Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Enbrel (Etanercept)
14 Completed Use of KC706 for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: KC706
15 Completed Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PI-0824
16 Terminated Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Dapsone
17 Active, not recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Interventions: Drug: General Corticotherapy;   Drug: Rituximab
18 Recruiting A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PRN1008
19 Recruiting Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
Condition: Oral Pemphigus Vulgaris
Interventions: Other: Autologous Platelet rich plasma;   Drug: Triamcinolone Acetonide
20 Recruiting A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Rituximab Versus MMF in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris (PV)
Interventions: Other: MMF placebo;   Drug: mycophenolate mofetil;   Drug: rituximab [MabThera/Rituxan];   Other: rituximab placebo

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.